- £1.5mn subscription and retail offer
- Wanda Health investment generates 2,077 per cent capital return in only six months
- £41mn directly held portfolio
- £65.7mn managed and third-party funds under management
- 68 per cent share price discount to proforma value of portfolio post equity raise
Aim-traded investment and fund management company EMV Capital (EMVC:49p), formerly Netscientific, is raising £1.5mn through a subscription and retail offer of new shares at 50p.
Specialising in the deep tech and life sciences sectors, EMV aims to deliver shareholder value by identifying and investing in companies with transformative technologies both within the UK and internationally. The strategy focuses on achieving capital returns through the profitable exits of selected portfolio companies, as well as generating carried interest from a growing funds practice, which surpassed £100mn of assets under management in the first half of 2024.